The Hung laboratory combines chemical and genomic approaches to define host-pathogen interactions and to reveal the critical pressure points of infectious disease. By using small organic molecules and applying systematic genetic perturbations, the lab hopes to gain new insight into bacterial responses to host immunity and chemotherapy and to establish new therapeutic paradigms for a variety of devastating pathogens, including Klebsiella pneumoniae, Pseudomonas aeruginosa and Mycobacterium tuberculosis.
Core Member and Co-Director of the Infectious Disease and Microbiome Program at the Broad Institute of MIT and Harvard
Associate Professor in the Department of Genetics at Harvard Medical School
Associate Professor in the Department of Molecular Biology at Massachusetts General Hospital
Associate Professor in the Department of Medicine at Harvard Medical School